https://www.acumenresearchandconsulting.com/
Home Services Industry Services Press Releases About Us Blogs Report Store Contact us

Generative AI in Healthcare Market Size - Global Industry, Share, Analysis, Trends and Forecast 2023 - 2032

Published : Nov 2023

Report ID: ARC3456

Pages : 250

Format : Generative AI in Healthcare Market Size - Global Industry, Share, Analysis, Trends and Forecast 2023 - 2032

CHAPTER 1. Industry Overview of Generative AI in Healthcare Market

1.1. Definition and Scope

1.1.1. Definition of Generative AI in Healthcare

1.1.2. Market Segmentation

1.1.3. Years Considered for the Study

1.1.4. Assumptions and Acronyms Used

1.1.4.1. Market Assumptions and Market Forecast

1.1.4.2. Acronyms Used in Global Generative AI in Healthcare Market

1.2. Summary

1.2.1. Executive Summary 

1.2.2. Generative AI in Healthcare Market By Application

1.2.3. Generative AI in Healthcare Market By Function

1.2.4. Generative AI in Healthcare Market By End User

1.2.5. Generative AI in Healthcare Market By Region

CHAPTER 2. Research Approach

2.1. Methodology 

2.1.1. Research Programs

2.1.2. Market Size Estimation

2.1.3. Market Breakdown and Data Triangulation

2.2. Data Source

2.2.1. Secondary Source

2.2.2. Primary Source

CHAPTER 3. Market Dynamics And Competition Analysis

3.1. Market Drivers

3.1.1. Driver 1

3.1.2. Driver 2

3.2. Restraints and Challenges

3.2.1. Restraint 1

3.2.2. Restraint 2

3.3. Growth Opportunities

3.3.1. Opportunity 1

3.3.2. Opportunity 2 

3.4. Porter’s Five Forces Analysis

3.4.1. Bargaining Power of Suppliers

3.4.2. Bargaining Power of Buyers

3.4.3. Threat of Substitute

3.4.4. Threat of New Entrants

3.4.5. Degree of Competition

3.5. Market Concentration Ratio and Market Maturity Analysis of Generative AI in Healthcare Market

3.5.1. Go To Market Strategy

3.5.1.1. Introduction

3.5.1.2. Growth

3.5.1.3. Maturity

3.5.1.4. Saturation

3.5.1.5. Possible Development

3.6. Technological Roadmap for Generative AI in Healthcare Market

3.7. Value Chain Analysis

3.7.1. List of Key Manufacturers 

3.7.2. List of Customers

3.7.3. Level of Integration

3.8. Price Trend of Key Raw Material

3.8.1. Raw Material Suppliers

3.8.2. Proportion of Manufacturing Cost Structure

3.8.2.1. Raw Material

3.8.2.2. Labor Cost

3.8.2.3. Manufacturing Expense

3.9. Regulatory Compliance

3.10. Competitive Landscape, 2022

3.10.1. Player Positioning Analysis

3.10.2. Key Strategies Adopted By Leading Players

CHAPTER 4. Manufacturing Plant Analysis

4.1. Manufacturing Plant Location and Establish Date of Major Manufacturers in 2022

4.2. R&D Status of Major Manufacturers in 2022

CHAPTER 5. Generative AI in Healthcare Market By Application

5.1. Introduction

5.2. Generative AI in Healthcare Revenue By Application

5.2.1. Generative AI in Healthcare Revenue (USD Billion) and Forecast, By Application, 2020-2032

5.2.2. Clinical

5.2.2.1. Clinical Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

5.2.2.2. Oncology

5.2.2.2.1. Oncology Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

5.2.2.3. Cardiovascular

5.2.2.3.1. Cardiovascular Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

5.2.2.4. Infectious Disease

5.2.2.4.1. Infectious Disease Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

5.2.2.5. Dermatology

5.2.2.5.1. Dermatology Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

5.2.2.6. Others

5.2.2.6.1. Others Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

5.2.3. System

5.2.3.1. System Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

5.2.3.2. Electronic Health Records

5.2.3.2.1. Electronic Health Records Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

5.2.3.3. Telemedicine

5.2.3.3.1. Telemedicine Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

5.2.3.4. Disease Diagnosis

5.2.3.4.1. Disease Diagnosis Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

5.2.3.5. Drug Interaction

5.2.3.5.1. Drug Interaction Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

CHAPTER 6. Generative AI in Healthcare Market By Function

6.1. Introduction

6.2. Generative AI in Healthcare Revenue By Function

6.2.1. Generative AI in Healthcare Revenue (USD Billion) and Forecast, By Function, 2020-2032

6.2.2. AI-Assisted Robotic Surgery

6.2.2.1. AI-Assisted Robotic Surgery Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

6.2.3. Workflow & Administrative Tasks

6.2.3.1. Workflow & Administrative Tasks Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

6.2.4. Aid Clinical Judgment/Diagnosis

6.2.4.1. Aid Clinical Judgment/Diagnosis Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

6.2.5. Virtual Nursing Assistants

6.2.5.1. Virtual Nursing Assistants Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

6.2.6. Image Analysis

6.2.6.1. Image Analysis Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

CHAPTER 7. Generative AI in Healthcare Market By End User

7.1. Introduction

7.2. Generative AI in Healthcare Revenue By End User

7.2.1. Generative AI in Healthcare Revenue (USD Billion) and Forecast, By End User, 2020-2032

7.2.2. Hospitals & Clinics

7.2.2.1. Hospitals & Clinics Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

7.2.3. Diagnostic Centers

7.2.3.1. Diagnostic Centers Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

7.2.4. Healthcare Organizations

7.2.4.1. Healthcare Organizations Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

7.2.5. Clinical Research

7.2.5.1. Clinical Research Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

7.2.6. Others

7.2.6.1. Others Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

CHAPTER 8. North America Generative AI in Healthcare Market By Country 

8.1. North America Generative AI in Healthcare Market Overview

8.2. U.S.

8.2.1. U.S. Generative AI in Healthcare Revenue (USD Billion) and Forecast By Application, 2020-2032

8.2.2. U.S. Generative AI in Healthcare Revenue (USD Billion) and Forecast By Function, 2020-2032

8.2.3. U.S. Generative AI in Healthcare Revenue (USD Billion) and Forecast By End User, 2020-2032

8.3. Canada

8.3.1. Canada Generative AI in Healthcare Revenue (USD Billion) and Forecast By Application, 2020-2032

8.3.2. Canada Generative AI in Healthcare Revenue (USD Billion) and Forecast By Function, 2020-2032

8.3.3. Canada Generative AI in Healthcare Revenue (USD Billion) and Forecast By End User, 2020-2032

8.4. North America PEST Analysis

CHAPTER 9. Europe Generative AI in Healthcare Market By Country

9.1. Europe Generative AI in Healthcare Market Overview

9.2. U.K.

9.2.1. U.K. Generative AI in Healthcare Revenue (USD Billion) and Forecast By Application, 2020-2032

9.2.2. U.K. Generative AI in Healthcare Revenue (USD Billion) and Forecast By Function, 2020-2032

9.2.3. U.K. Generative AI in Healthcare Revenue (USD Billion) and Forecast By End User, 2020-2032

9.3. Germany

9.3.1. Germany Generative AI in Healthcare Revenue (USD Billion) and Forecast By Application, 2020-2032

9.3.2. Germany Generative AI in Healthcare Revenue (USD Billion) and Forecast By Function, 2020-2032

9.3.3. Germany Generative AI in Healthcare Revenue (USD Billion) and Forecast By End User, 2020-2032

9.4. France

9.4.1. France Generative AI in Healthcare Revenue (USD Billion) and Forecast By Application, 2020-2032

9.4.2. France Generative AI in Healthcare Revenue (USD Billion) and Forecast By Function, 2020-2032

9.4.3. France Generative AI in Healthcare Revenue (USD Billion) and Forecast By End User, 2020-2032

9.5. Spain

9.5.1. Spain Generative AI in Healthcare Revenue (USD Billion) and Forecast By Application, 2020-2032

9.5.2. Spain Generative AI in Healthcare Revenue (USD Billion) and Forecast By Function, 2020-2032

9.5.3. Spain Generative AI in Healthcare Revenue (USD Billion) and Forecast By End User, 2020-2032

9.6. Rest of Europe

9.6.1. Rest of Europe Generative AI in Healthcare Revenue (USD Billion) and Forecast By Application, 2020-2032

9.6.2. Rest of Europe Generative AI in Healthcare Revenue (USD Billion) and Forecast By Function, 2020-2032

9.6.3. Rest of Europe Generative AI in Healthcare Revenue (USD Billion) and Forecast By End User, 2020-2032

9.7. Europe PEST Analysis

CHAPTER 10. Asia Pacific Generative AI in Healthcare Market By Country

10.1. Asia Pacific Generative AI in Healthcare Market Overview

10.2. China

10.2.1. China Generative AI in Healthcare Revenue (USD Billion) and Forecast By Application, 2020-2032

10.2.2. China Generative AI in Healthcare Revenue (USD Billion) and Forecast By Function, 2020-2032

10.2.3. China Generative AI in Healthcare Revenue (USD Billion) and Forecast By End User, 2020-2032

10.3. Japan

10.3.1. Japan Generative AI in Healthcare Revenue (USD Billion) and Forecast By Application, 2020-2032

10.3.2. Japan Generative AI in Healthcare Revenue (USD Billion) and Forecast By Function, 2020-2032

10.3.3. Japan Generative AI in Healthcare Revenue (USD Billion) and Forecast By End User, 2020-2032

10.4. India

10.4.1. India Generative AI in Healthcare Revenue (USD Billion) and Forecast By Application, 2020-2032

10.4.2. India Generative AI in Healthcare Revenue (USD Billion) and Forecast By Function, 2020-2032

10.4.3. India Generative AI in Healthcare Revenue (USD Billion) and Forecast By End User, 2020-2032

10.5. Australia

10.5.1. Australia Generative AI in Healthcare Revenue (USD Billion) and Forecast By Application, 2020-2032

10.5.2. Australia Generative AI in Healthcare Revenue (USD Billion) and Forecast By Function, 2020-2032

10.5.3. Australia Generative AI in Healthcare Revenue (USD Billion) and Forecast By End User, 2020-2032

10.6. South Korea

10.6.1. South Korea Generative AI in Healthcare Revenue (USD Billion) and Forecast By Application, 2020-2032

10.6.2. South Korea Generative AI in Healthcare Revenue (USD Billion) and Forecast By Function, 2020-2032

10.6.3. South Korea Generative AI in Healthcare Revenue (USD Billion) and Forecast By End User, 2020-2032

10.7. Rest of Asia-Pacific

10.7.1. Rest of Asia-Pacific Generative AI in Healthcare Revenue (USD Billion) and Forecast By Application, 2020-2032

10.7.2. Rest of Asia-Pacific Generative AI in Healthcare Revenue (USD Billion) and Forecast By Function, 2020-2032

10.7.3. Rest of Asia-Pacific Generative AI in Healthcare Revenue (USD Billion) and Forecast By End User, 2020-2032

10.8. Asia Pacific PEST Analysis

CHAPTER 11. Latin America Generative AI in Healthcare Market By Country

11.1. Latin America Generative AI in Healthcare Market Overview

11.2. Brazil

11.2.1. Brazil Generative AI in Healthcare Revenue (USD Billion) and Forecast By Application, 2020-2032

11.2.2. Brazil Generative AI in Healthcare Revenue (USD Billion) and Forecast By Function, 2020-2032

11.2.3. Brazil Generative AI in Healthcare Revenue (USD Billion) and Forecast By End User, 2020-2032

11.3. Mexico

11.3.1. Mexico Generative AI in Healthcare Revenue (USD Billion) and Forecast By Application, 2020-2032

11.3.2. Mexico Generative AI in Healthcare Revenue (USD Billion) and Forecast By Function, 2020-2032

11.3.3. Mexico Generative AI in Healthcare Revenue (USD Billion) and Forecast By End User, 2020-2032

11.4. Rest of Latin America

11.4.1. Rest of Latin America Generative AI in Healthcare Revenue (USD Billion) and Forecast By Application, 2020-2032

11.4.2. Rest of Latin America Generative AI in Healthcare Revenue (USD Billion) and Forecast By Function, 2020-2032

11.4.3. Rest of Latin America Generative AI in Healthcare Revenue (USD Billion) and Forecast By End User, 2020-2032

11.5. Latin America PEST Analysis

CHAPTER 12. Middle East & Africa Generative AI in Healthcare Market By Country 

12.1. Middle East & Africa Generative AI in Healthcare Market Overview

12.2. GCC

12.2.1. GCC Generative AI in Healthcare Revenue (USD Billion) and Forecast By Application, 2020-2032

12.2.2. GCC Generative AI in Healthcare Revenue (USD Billion) and Forecast By Function, 2020-2032

12.2.3. GCC Generative AI in Healthcare Revenue (USD Billion) and Forecast By End User, 2020-2032

12.3. South Africa

12.3.1. South Africa Generative AI in Healthcare Revenue (USD Billion) and Forecast By Application, 2020-2032

12.3.2. South Africa Generative AI in Healthcare Revenue (USD Billion) and Forecast By Function, 2020-2032

12.3.3. South Africa Generative AI in Healthcare Revenue (USD Billion) and Forecast By End User, 2020-2032

12.4. Rest of Middle East & Africa

12.4.1. Rest of Middle East & Africa Generative AI in Healthcare Revenue (USD Billion) and Forecast By Application, 2020-2032

12.4.2. Rest of Middle East & Africa Generative AI in Healthcare Revenue (USD Billion) and Forecast By Function, 2020-2032

12.4.3. Rest of Middle East & Africa Generative AI in Healthcare Revenue (USD Billion) and Forecast By End User, 2020-2032

12.5. Middle East & Africa PEST Analysis

CHAPTER 13. Player Analysis Of Generative AI in Healthcare Market

13.1. Generative AI in Healthcare Market Company Share Analysis

13.2. Competition Matrix

13.2.1. Competitive Benchmarking Of Key Players By Price, Presence, Market Share, And R&D Investment

13.2.2. New Product Launches and Product Enhancements

13.2.3. Mergers And Acquisition In Global Generative AI in Healthcare Market

13.2.4. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements

CHAPTER 14. Company Profile

14.1. Syntegra

14.1.1. Company Snapshot

14.1.2. Business Overview

14.1.3. Financial Overview

14.1.3.1. Revenue (USD Billion), 2022

14.1.3.2. Syntegra 2022 Generative AI in Healthcare Business Regional Distribution

14.1.4. Product /Service and Specification

14.1.5. Recent Developments & Business Strategy

14.2. Saxon

14.3. NioyaTech

14.4. Microsoft Corporation

14.5. IBM Watson

14.6. OpenAI

14.7. Google LLC

14.8. Neuralink Corporation

14.9. Tencent Holdings Ltd.

14.10. Johnson & Johnson

14.11. Oracle

14.12. Tencent Holdings Ltd.

Frequently Asked Questions

How big is the generative AI in healthcare market?

The market size of generative AI in healthcare was USD 1.2 Billion in 2022.

What is the CAGR of the global generative AI in healthcare market from 2023 to 2032?

The CAGR of generative AI in healthcare is 35.8% during the analysis period of 2023 to 2032.

Which are the key players in the generative AI in healthcare market?

The key players operating in the global market are including Syntegra, Saxon, NioyaTech, Microsoft Corporation, IBM Watson, OpenAI, Google LLC, Neuralink Corporation, Tencent Holdings Ltd., Johnson & Johnson, Oracle, and Tencent Holdings Ltd.

Which region dominated the global generative AI in healthcare market share?

North America held the dominating position in generative AI in healthcare industry during the analysis period of 2023 to 2032.

Which region registered fastest CAGR from 2023 to 2032?

Asia-Pacific region exhibited fastest growing CAGR for market of generative AI in healthcare during the analysis period of 2023 to 2032.

What are the current trends and dynamics in the global generative AI in healthcare industry?

The current trends and dynamics in the generative AI in healthcare industry include increasing demand for personalized medicine, advancements in AI technology and healthcare data analytics, and growing adoption of generative AI for medical imaging and diagnostics.

Which function held the maximum share in 2022?

The medical imaging analysis function held the maximum share of the generative AI in healthcare industry.

Select Licence Type

Single User

US$ 4500

Multi User

US$ 9000

Excel Datapack

US$ 2000

Why Acumen Research And Consulting

100%

Customer Satisfaction

24x7

Availability - we are always there when you need us

200+

Fortune 50 Companies trust Acumen Research and Consulting

80%

of our reports are exclusive and first in the industry

100%

more data and analysis

1000+

reports published till date